Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

They also have benefits for heart, immune, and gut health. This dark red fruit, found in wet habitats in parts of the United States, Canada, Chile, and Europe, is known for its tart flavor.

Carolina Rudah / iStock What is the Maximum Recommended Semaglutide Dose for Weight Loss? The maximum recommended semaglutide dose for weight loss is 2.4 milligrams (mg) per week. Your healthcare ...

Real-time index price for S&P Smallcap 600 (IQY), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...

Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue(i) grew by 20% compared to Q4 2023. Pipeline ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're about to lose access.

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide) and Novo Nordisk's GLP-1 agonist Wegovy (semaglutide) have shown experimentally what has been ...

MediaNama asked MobiKwik how their customers would benefit from the inclusion of an e-wallet for the RBI’s CBDC, given the prevalence of UPI transactions. According to MobiKwik, the integration ...

the Zepbound pen can cost around $1,000 per month, while single-dose vials come in limited dose ranges but cost less. To learn more about GLP-1 drugs, read our articles on Mounjaro, Wegovy ...